News Press

SOLNATIDE has been approved for the treatment of COVID-19 patients suffering from pulmonary oedema and acute respiratory distress syndrome by the Italian Medicines Agency and the Ethics Committee of the National Institute for Infectious Diseases (Lazzaro Spallanzani-Rome)

29 Aprile 2020

Comunicato stampa

Leggi il comunicato stampa, clicca qui

Torna a: News